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Background: Diabetes mellitus has reached epidemic proportions and affects more than 170 
million individuals worldwide. Global estimates for the year 2010 predict a further growth of 
almost 50%. In recent past, role of inflammation in causation of both Diabetes and its 
complications has gained acceptance. Initially, hyperglycemia was thought to be the factor 
causing inflammation, but recently, obesity has gained attraction as probable cause of 
inflammation. 
Objective: The objective of this study was to assess the levels of markers of inflammation in 
Diabetic patients, with uncontrolled hyperglycemia, before and after treatment with Oral 
hypoglycemic agents or insulin. 
Materials and Methods: Blood samples were collected from 30 Type 2 Diabetes patients 
presenting to J.N.M.C.H. endocrinology O.P.D. Also, age matched controls were taken from 
healthy volunteers. Voluntary informed consent was taken from all study subjects for 
participation in the study. Samples were taken before treatment, after 24 weeks and after 48 
weeks of treatment. Levels of TNF-α and IL-6 were assessed in sera using ELISA. 
Results: The levels of TNF-α and IL-6 were elevated in diabetic patients and were significantly 
reduced after treatment. While in diabetic individuals, TNF-α was 40 fold higher than healthy 
volunteers, IL-6 levels were 13 fold higher. After 24 weeks of treatment, there was 2.5 fold 
decrease in levels of both TNF-α and IL-6. After 48 weeks of treatment, while TNF-α levels 
showed a 7 fold reduction, IL-6 levels were reduced by 5 fold. 
Conclusion: Thus, the results indicate that hyperglycemia significantly causes increase in 
inflammatory markers like TNF-α and IL-6, which further contribute to pathogenesis of Diabetes 
mellitus type 2 as well as its complications such as atherosclerosis and neuropathy. 
 
Published In Proceedings of Diabetes Mellitus, Insulin Action and Resistance, held from January 
22 - 27, 2008, Beaver Run Resort, Breckenridge, U.S.A. 
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